<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002520"><a href="http://purl.obolibrary.org/obo/MONDO_0002520">MONDO:0002520</a></h3>
<p><strong>Label:</strong> acute porphyria</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0015104">MONDO:0015104</a> (porphyria cutanea tarda), <a href="http://purl.obolibrary.org/obo/MONDO_0008296">MONDO:0008296</a> (familial porphyria cutanea tarda), <a href="http://purl.obolibrary.org/obo/MONDO_0001676">MONDO:0001676</a> (erythropoietic protoporphyria),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_176090">OMIM:176090</a>, <a href="http://www.orpha.net/ORDO/Orphanet_443062">Orphanet:443062</a>, <a href="http://www.orpha.net/ORDO/Orphanet_101330">Orphanet:101330</a>, <a href="http://purl.obolibrary.org/obo/OMIM_176100">OMIM:176100</a>, <a href="http://purl.obolibrary.org/obo/OMIM_177000">OMIM:177000</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300752">OMIM:300752</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79278">Orphanet:79278</a>, <a href="http://www.orpha.net/ORDO/Orphanet_95159">Orphanet:95159</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000964">HP:0000964</a> (Eczema) and <a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) and <a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) and <a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011122">HP:0011122</a> (Abnormality of skin physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011122">HP:0011122</a> (Abnormality of skin physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010472">HP:0010472</a> (Abnormality of the heme biosynthetic pathway) and <a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 62.50%</li>
</ul>
</body>
</html>
